Symbols

CPHI

China Pharma Holdings·AMEX

--(--)

Signals Analysis

Bullish signal 0

Bearish signal 1

Consecutive Revenue Decline

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About CPHI

China Pharma Holdings, Inc.

A Chinese pharmaceutical company that develops, manufactures, and markets specialty pharmaceutical products in China

Industry

Pharmaceutical

Established Date

01/28/1999

Listing Date

09/30/2009

Exchange

American Stock Exchange

Full-time Employees

215

Fiscal Year Ends

12-31

Website

www.chinapharmaholdings.com

Security Type

Common stock

Office address

Second Floor No. 17 Jinpan Road Haikou Hainan Province China 570216

Business

Drug development, production and sales

Introduction

China National Pharmaceutical Holdings Limited was established on January 28, 1999. Through its wholly-owned subsidiary Hainan Hesheng Medical Biotechnology Co., Ltd. and its subsidiaries in China, the company is engaged in the development, production and marketing of medicines for human use. Its product portfolio includes basic generic drugs, first generic drugs and modern traditional Chinese medicine.

Company Financials

EPS

CPHI has released its 2025 Q3 earnings. EPS was reported at -0.17, versus the expected 0, missing expectations. The chart below visualizes how CPHI has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

CPHI has released its 2025 Q3 earnings report, with revenue of 756.22K, reflecting a YoY change of -31.26%, and net profit of -651.48K, showing a YoY change of 41.72%. The Sankey diagram below clearly presents CPHI's revenue sources and cost distribution.